rs1031739

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138982.4(MAPK10):​c.-7+46006C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 152,050 control chromosomes in the GnomAD database, including 9,039 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9039 hom., cov: 32)
Exomes 𝑓: 0.50 ( 0 hom. )

Consequence

MAPK10
NM_138982.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0420

Publications

3 publications found
Variant links:
Genes affected
MAPK10 (HGNC:6872): (mitogen-activated protein kinase 10) The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]
MAPK10 Gene-Disease associations (from GenCC):
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.38 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138982.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK10
NM_138982.4
MANE Select
c.-7+46006C>T
intron
N/ANP_620448.1
MAPK10
NM_001318069.2
c.-7+46006C>T
intron
N/ANP_001304998.1
MAPK10
NM_001318067.1
c.-7+46006C>T
intron
N/ANP_001304996.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK10
ENST00000641462.2
MANE Select
c.-7+46006C>T
intron
N/AENSP00000493435.1
MAPK10
ENST00000638225.1
TSL:1
c.-148+46006C>T
intron
N/AENSP00000491866.1
MAPK10
ENST00000395160.9
TSL:1
c.-7+46006C>T
intron
N/AENSP00000378589.5

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
51918
AN:
151930
Hom.:
9029
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.278
Gnomad AMI
AF:
0.458
Gnomad AMR
AF:
0.363
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.264
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.337
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.320
GnomAD4 exome
AF:
0.500
AC:
1
AN:
2
Hom.:
0
AF XY:
0.500
AC XY:
1
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.342
AC:
51965
AN:
152048
Hom.:
9039
Cov.:
32
AF XY:
0.338
AC XY:
25137
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.278
AC:
11524
AN:
41476
American (AMR)
AF:
0.363
AC:
5550
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1187
AN:
3468
East Asian (EAS)
AF:
0.265
AC:
1369
AN:
5168
South Asian (SAS)
AF:
0.314
AC:
1515
AN:
4820
European-Finnish (FIN)
AF:
0.337
AC:
3561
AN:
10554
Middle Eastern (MID)
AF:
0.346
AC:
101
AN:
292
European-Non Finnish (NFE)
AF:
0.383
AC:
26064
AN:
67972
Other (OTH)
AF:
0.320
AC:
676
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1748
3495
5243
6990
8738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.355
Hom.:
1590
Bravo
AF:
0.340
Asia WGS
AF:
0.256
AC:
889
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.8
DANN
Benign
0.54
PhyloP100
0.042
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1031739; hg19: chr4-87229677; API